Browsing by Subject "Severe Acute Respiratory Syndrome"
Now showing items 21-40 of 57
-
Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019
(2020-05-14)Objective To assess the efficacy and safety of hydroxychloroquine plus standard of care compared with standard of care alone in adults with coronavirus disease 2019 (covid-19). Design Multicentre, open label, randomised ... -
Immunity after COVID-19: protection or sensitization ?
(2020-05-23)Motivated by historical and present clinical observations, we discuss the possible unfavorable evolution of the immunity (similar to documented antibody-dependent enhancement scenarios) after a first infection with COVID-19. ... -
Laparoscopic surgery in COVID-19 Era—Safety and Ethical Issues
(2020)Background: The paper aims to review the available evidence regarding the health risk of the aerosolization induced by laparoscopy induced and impact of the COVID-19 pandemic upon minimally invasive surgery. (2) Materials ... -
Listado de test rápido para detección de anticuerpos CoVID-19 de la Autoridades Reguladoras Nacionales pertenecientes al Foro Internacional de Reguladores de Dispositivos Médicos
(2020-04-03)El Instituto de Salud Pública de Chile (ISP) informa el listado de kit de anticuerpos IgG e IgM que se encuentran reportados en los sitios web oficiales de las autoridades reguladoras de alta vigilancia sanitaria en ... -
Listado de test rápido para detección de anticuerpos CoVID-19 de la Autoridades Reguladoras Nacionales pertenecientes al Foro Internacional de Reguladores de Dispositivos Médicos
(2020-04-14)El Instituto de Salud Pública de Chile (ISP) informa el listado de kit de anticuerpos IgG e IgM que se encuentran reportados en los sitios web oficiales de autoridades reguladoras de alta vigilancia sanitaria en dispositivos ... -
Long-term clinical outcomes in survivors of coronavirus outbreaks after hospitalization or ICU admission: a systematic review and meta-analysis of follow-u studies
(2020-04-22)Objective: To determine the long-term clinical problems in adult survivors of coronavirus (CoV) infection [Coronavirus disease 2019 (COVID-19), Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome ... -
Long-term clinical outcomes in survivors of SARS and MERS
(2020-07-20)Citation: Ahmed H, Patel K, Greenwood DC, et al. Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: ... -
Lopinavir-ritonavir for COVID-19: A living systematic review
(2020-07-15)Objective: Provide a timely, rigorous, and continuously updated summary of the evidence on the role of lopinavir/ritonavir in the treatment of patients with COVID-19. Methods: We conducted searches in the special L·OVE ... -
MERS-CoV as an emerging respiratory illness: A review of prevention methods
(2019-12)Introduction: Middle East Respiratory Coronavirus Virus (MERS-CoV) first emerged from Saudi Arabia in 2012 and has since been recognized as a significant human respiratory pathogen on a global level. Methods: In this ... -
Monolaurina na prevenção e tratamento de pacientes com COVID-19 (maio de 2020)
(2020-05)Trata-se de despacho proveniente do Centro de Operações de Emergências em Saúde Pública (COE) e encaminhado ao Departamento de Gestão e Incorporação de Tecnologias e Inovação em Saúde (DGITIS/SCTIE/MS). O despacho em ... -
The Natural History of Severe Acute Respiratory Syndrome Coronavirus 2–Related Multisystem Inflammatory Syndrome in Children: A Systematic Review
(2020-09-14)Background: The clinical manifestations and natural history of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–related multisystem inflammatory syndrome in children (MIS-C) are poorly defined. Using a systematic ... -
Neurological associations of COVID-19
(2020-07-02)Background: The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is of a scale not seen since the 1918 influenza pandemic. Although the predominant clinical presentation is with ... -
No evidence supports the use of ether and chloroform inhalation for treating COVID-19
(2020-03)Dear Editor, SARS-CoV-2 has been spreading rapidly across the world as well as the number of fake news on social media regarding harmful or non-harmful treatments which are ineffective for treating COVID-19. In Brazil, the ... -
Noninvasive mechanical ventilation in high-risk pulmonary infections: a clinical review
(2014-05-11)[Abstract]. The aim of this article was to review the role of noninvasive ventilation (NIV) in acute pulmonary infectious diseases, such as severe acute respiratory syndrome (SARS), H1N1 and tuberculosis, and to assess the ... -
Nota Informativa: Recomendações para adequações das ações de vigilância e cuidado ao paciente com doença de Chagas frente à situação epidemiológica da COVID-19 (15 de abril de 2020)
(2020-04-15)A doença de Chagas (DC) é uma condição crônica, que leva aproximadamente 40% dos indivíduos infectados a desenvolverem sinais clínicos com envolvimento cardíaco e digestivo. Estima-se que esta população no país seja em ... -
Obesity a predictor of outcomes of COVID‐19 hospitalized patients‐ A systematic Review and Meta‐Analysis
(2020-09-25)Background: COVID‐19 pandemic is a global health crisis. Very few studies have reported association between obesity and severity of COVID‐19. In this meta‐analysis, we assessed the association of obesity and outcomes in ... -
Ongoing Living Update of Potential COVID-19 Therapeutics: summary of rapid systematic reviews. Rapid Review, 22 April 2020
(2020-04-22)This document includes the results of a rapid systematic review of current available literature. The information included in this review reflects the evidence as of the date posted in the document. Yet, recognizing that ... -
Pivotal Role of Convalescent Plasma in Managing Emerging Infectious Diseases
(2020-04-02)Infectious diseases remain one of the top 10 global health threats as announced by the World Health Organization. The emergence of new pathogens for which there is no effective treatment has redrawn the attention to the ... -
Probiotics against viruses; COVID-19 is a paper tiger: A Systematic Review
(2020-09-17)Background: Probiotics can improve immune function for prevention and management of viral infections like SARS-CoV-2 infection (COVID-19 disease). Methods: We searched on PubMed, EMBASE, Google Scholar, Science Direct, ... -
The production of antibodies for SARS-CoV-2 and its clinical implication
(2020-04-24)Background: Severe acute respiratory syndrome coronavirus 2(SARS-CoV-2), a novel betacoronavirus, has caused an outburst of pneumonia cases in Wuhan, China. We report the production of specific IgM and IgG antibodies after ...